Integral Health Asset Management, LLC 13F holdings, Q1 2025
Holdings as of March 31, 2025 · filings on SEC EDGAR · latest filing →
Integral Health Asset Management, LLC disclosed 76 US equity positions worth $902.7m in its Q1 2025 13F filing. The largest position was INSM at 13.1% of the reported book, followed by BSX and CYTK. Against the Q4 2024 filing, it opened 18 new positions, added to 12 and reduced 15 among the top 50 holdings.
What did Integral Health Asset Management, LLC own in Q1 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2024 |
|---|---|---|---|---|---|---|---|
| 1 | INSM INSMED INC | Healthcare | 13.1% | $118.2m | 1,550,000 | 0% | held |
| 2 | BSX BOSTON SCIENTIFIC CORP | Healthcare | 7.3% | $65.6m | 650,000 | 18% | added |
| 3 | CYTK CYTOKINETICS INC | Healthcare | 4.9% | $44.2m | 1,100,000 | 10% | added |
| 4 | THC TENET HEALTHCARE CORP | Healthcare | 4.1% | $37.0m | 275,000 | -31% | reduced |
| 5 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 4.0% | $36.5m | 2,300,000 | 163% | added |
| 6 | ELV ELEVANCE HEALTH INC | Healthcare | 3.1% | $28.3m | 65,000 | – | new |
| 7 | NVS NOVARTIS AG | Healthcare | 3.1% | $27.9m | 250,000 | – | new |
| 8 | VERA VERA THERAPEUTICS INC | Healthcare | 3.1% | $27.6m | 1,150,000 | 0% | held |
| 9 | EHC ENCOMPASS HEALTH CORP | Healthcare | 3.0% | $27.3m | 270,000 | -10% | reduced |
| 10 | MDT MEDTRONIC PLC | Healthcare | 3.0% | $27.0m | 300,000 | 100% | added |
| 11 | GILD GILEAD SCIENCES INC | Healthcare | 2.2% | $19.6m | 175,000 | -12% | reduced |
| 12 | BAX BAXTER INTL INC | Healthcare | 1.9% | $17.1m | 500,000 | – | new |
| 13 | FMS FRESENIUS MEDICAL CARE AG | Healthcare | 1.9% | $16.9m | 680,000 | 13% | added |
| 14 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 1.8% | $16.6m | 150,000 | -6% | reduced |
| 15 | ASND ASCENDIS PHARMA A/S | Healthcare | 1.7% | $15.6m | 100,000 | – | new |
| 16 | EWTX EDGEWISE THERAPEUTICS INC | 1.6% | $14.8m | 675,000 | 23% | added | |
| 17 | BTSG BRIGHTSPRING HEALTH SVCS INC | Healthcare | 1.6% | $14.0m | 775,000 | -18% | reduced |
| 18 | CVS CVS HEALTH CORP | Healthcare | 1.5% | $13.6m | 200,000 | -60% | reduced |
| 19 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 1.5% | $13.5m | 50,000 | 11% | added |
| 20 | QURE UNIQURE NV | 1.5% | $13.2m | 1,250,000 | 14% | added | |
| 21 | 2655787D BLUEPRINT MEDICINES CORP | 1.4% | $12.8m | 145,000 | -47% | reduced | |
| 22 | ABBV ABBVIE INC | Healthcare | 1.4% | $12.6m | 60,000 | – | new |
| 23 | RDNT RADNET INC | Healthcare | 1.4% | $12.4m | 250,000 | – | new |
| 24 | GEHC GE HEALTHCARE TECHNOLOGIES I | Healthcare | 1.3% | $12.1m | 150,000 | – | new |
| 25 | KRYS KRYSTAL BIOTECH INC | Healthcare | 1.2% | $10.8m | 60,000 | 9% | added |
| 26 | INSP INSPIRE MED SYS INC | Healthcare | 1.1% | $10.4m | 65,000 | -35% | reduced |
| 27 | TARS TARSUS PHARMACEUTICALS INC | Healthcare | 1.1% | $10.3m | 200,000 | -43% | reduced |
| 28 | PEN PENUMBRA INC | Healthcare | 1.0% | $9.4m | 35,000 | – | new |
| 29 | EW EDWARDS LIFESCIENCES CORP | Healthcare | 1.0% | $9.1m | 125,000 | – | new |
| 30 | RVMD REVOLUTION MEDICINES INC | Healthcare | 1.0% | $8.8m | 250,000 | -55% | reduced |
| 31 | MCK MCKESSON CORP | Healthcare | 0.9% | $8.1m | 12,000 | -66% | reduced |
| 32 | MLTX MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 0.9% | $7.8m | 200,000 | 0% | held |
| 33 | TEVA TEVA PHARMACEUTICAL INDS LTD | Healthcare | 0.9% | $7.7m | 500,000 | 0% | held |
| 34 | ETNBGBP 89BIO INC | 0.8% | $7.6m | 1,050,000 | 5% | added | |
| 35 | PFE PFIZER INC | Healthcare | 0.8% | $7.6m | 300,000 | – | new |
| 36 | ACHC ACADIA HEALTHCARE COMPANY IN | Healthcare | 0.8% | $7.6m | 250,000 | -17% | reduced |
| 37 | MASI* MASIMO CORP | 0.8% | $7.5m | 45,000 | – | new | |
| 38 | WAT WATERS CORP | Healthcare | 0.8% | $7.4m | 20,000 | -33% | reduced |
| 39 | VRNA VERONA PHARMA PLC | 0.8% | $7.3m | 115,000 | – | new | |
| 40 | DXCM DEXCOM INC | Healthcare | 0.8% | $6.8m | 100,000 | -33% | reduced |
| 41 | RGNX REGENXBIO INC | Healthcare | 0.7% | $6.6m | 925,000 | 3% | added |
| 42 | BMY BRISTOL-MYERS SQUIBB CO | Healthcare | 0.7% | $6.1m | 100,000 | -71% | reduced |
| 43 | ROIV ROIVANT SCIENCES LTD | Healthcare | 0.7% | $6.1m | 600,000 | – | new |
| 44 | TARA PROTARA THERAPEUTICS INC | 0.7% | $6.0m | 1,400,000 | 0% | held | |
| 45 | IQV IQVIA HLDGS INC | Healthcare | 0.6% | $5.3m | 30,000 | – | new |
| 46 | CRSP CRISPR THERAPEUTICS AG | Healthcare | 0.6% | $5.1m | 150,000 | – | new |
| 47 | PTCT PTC THERAPEUTICS INC | Healthcare | 0.6% | $5.1m | 100,000 | – | new |
| 48 | ALKS ALKERMES PLC | Healthcare | 0.5% | $5.0m | 150,000 | – | new |
| 49 | DYN DYNE THERAPEUTICS INC | Healthcare | 0.5% | $4.7m | 450,000 | 200% | added |
| 50 | LH LABCORP HOLDINGS INC | Healthcare | 0.5% | $4.7m | 20,000 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.